$OCGN seeing CureVac on CNBC kind of grinds my gears, over $100 per share and they are still early with whole thing, expecting getting approved mid year and start shipping by end of the year. If we could just see that signed deal, would be already at $10, losing momentum here. I'm not selling, no matter what 🚀
  • 10
10 Likes